Phase 1 Fungal Infection Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Not Yet Recruiting

Phase 1

Safety, Tolerability, and Pharmacokinetics of Oral SCY-247 in Healthy Subjects: Part 4

Fungal Infection

SCYNEXIS, Inc24 enrolled1 locationACTRN12624001393549

Completed

Phase 1

Comparative assessment of the absorption of a generic formulation of 40 mg/mL posaconazole oral suspension against the innovator posaconazole oral suspension conducted under fed conditions in healthy male & female volunteers

Fungal infections

Zenith Technology Corp Ltd36 enrolled1 locationACTRN12617001219370

Not Yet Recruiting

Phase 1

Pharmacokinetics and Safety of Solid Oral Posaconazole(SCH 56592) in Subjects at High Risk for Invasive Fungal Infections

High Risk for Invasive Fungal Infection due to: - Hematopoietic stem cell transplant (HSCT) recipients undergoing treatment for graft-versus-host disease (GVHD)High Risk for Invasive Fungal Infection due to: - Expected neutropenia (low white blood cell count) due to chemotherapy for Acute Myelogenous Leukaemia (AML) or Myelodysplastic Syndrome (MDS)

Schering-Plough Pty limited160 enrolled1 locationACTRN12611000364976